SCHEMBL4907671

SCHEMBL4907671

CCc1ccc(S(=O)(=O)NCCc2ccc(Oc3ccccc3)cc2)cc1C(=O)OC

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.53
POLB P06746 1/20 0.53
AKR1C3 P42330 3/20 0.53
MEN1 O00255 1/20 0.51
GAA P10253 1/20 0.51
KMT2A Q03164 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.50
TBXA2R P21731 1/20 0.49
TBXAS1 P24557 1/20 0.49
SGMS1 Q86VZ5 2/20 0.48
MAPT P10636 2/20 0.48
SFRP1 Q8N474 1/20 0.48
MMP2 P08253 3/20 0.47
CA12 O43570 2/20 0.47
CA1 P00915 2/20 0.47
CA2 P00918 2/20 0.47
CA9 Q16790 2/20 0.47
ADAMTS4 O75173 1/20 0.47
MMP13 P45452 1/20 0.47
MMP14 P50281 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4906430 0.92 AKR1C3 (0.56) ALDH1A1POLBAKR1C3KMT2ASMN1; SMN2
SCHEMBL4906132 0.91 ALDH1A1 (0.58) ALDH1A1POLBAKR1C3MEN1KMT2A
SCHEMBL4902977 0.91 MAPT (0.54) ALDH1A1AKR1C3MEN1KMT2ASMN1; SMN2
SCHEMBL4903854 0.90 ALDH1A1 (0.48) ALDH1A1POLBAKR1C3MEN1GAA
SCHEMBL4905550 0.90 ALDH1A1 (0.51) ALDH1A1POLBAKR1C3MEN1KMT2A
SCHEMBL4908270 0.90 TBXAS1 (0.53) ALDH1A1AKR1C3MEN1GAAKMT2A
SCHEMBL4903809 0.89 ALDH1A1 (0.55) ALDH1A1POLBAKR1C3MEN1GAA
SCHEMBL4903953 0.89 PKM (0.48) ALDH1A1POLBAKR1C3MEN1GAA
SCHEMBL4895673 0.88 ALDH1A1 (0.46) ALDH1A1POLBAKR1C3MEN1GAA
SCHEMBL4906091 0.86 MAPT (0.49) ALDH1A1AKR1C3MEN1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds HAMANAKA ERNEST S 2006-10-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARA, PPARG, PPARD ALDH1A1 2664/4885POLB 1488/4885AKR1C3 1604/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD ALDH1A1 2956/4885POLB 1807/4885AKR1C3 1645/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.